Hyundai Motor Honorary Chairman Chung Mong-koo donates 10 billion won to establish Vaccine Innovation Center

  • Oops!
    Something went wrong.
    Please try again later.
·1-min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
Hyundai Motor Group's Honorary Chairman Chung Mong-koo (right) will donate 10 billion won to Korea University Foundation to establish and operate 'Chung Mong-koo Vaccine Innovation Center'.
Hyundai Motor Group's Honorary Chairman Chung Mong-koo (right) will donate 10 billion won to Korea University Foundation to establish and operate 'Chung Mong-koo Vaccine Innovation Center'.

Seoul [South Korea], September 1 (ANI/Global Economic Reporter): Hyundai Motor Group's Honorary Chairman Chung Mong-koo will donate 10 billion won to the Korea University Foundation to establish and operate 'Chung Mong-koo Vaccine Innovation Center,' which has been promoted by Korea University Medical Center.

Hyundai Motor Group and Korea University Foundation held a donation agreement ceremony at the Inchon Memorial Hall of Korea University on the 31st. On behalf of Honorary Chairman Chung Mong-koo, Hyundai Motor Group Chairman Chung Eui-sun attended. Korea University Foundation Chairman Kim Jae-ho also participated together. President Chung Jin-taek of Korea University, Vice President Kim Young-hoon, President Kim Geol and President Gong Young-woon of Hyundai Motor Group also joined.

According to Hyundai Motor Group, Honorary Chairman Chung said, "In order to help the people who support the group, we decided to donate to the vaccine innovation center, which will contribute to development of Korean domestic vaccines. We hope it will help to overcome pandemic and get out health and happiness back."

Honorary Chairman Chung Mong-koo has emphasized his belief that the company should reply to the people who have supported the group. It is analyzed that the donation to the vaccine innovation center is a part of this philosophy of social contribution.

The donation will be delivered to Korea University Medical Center, which will run the "'Chung Mong-koo Vaccine Innovation Center,' and will be used to develop domestic vaccines and expand research infrastructure for prevention and treatment of global infectious diseases after COVID-19. (ANI/Global Economic)

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting